Advertisement
AXON vs CORT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and CORT is a Hold.
AXON in upward trend: price may jump up because it broke its lower Bollinger Band on November 06, 2026
AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 26 of 33 cases where AXON's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXON as a result. In 55 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
The Moving Average Convergence Divergence Histogram (MACD) for AXON turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 30 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
The 50-day moving average for AXON moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 66 (best 1 - 100 worst), indicating fairly steady price growth. AXON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.920) is normal, around the industry mean (5.050). AXON has a moderately high P/E Ratio (126.721) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).
CORT sees MACD Histogram just turned negative
CORT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 14, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 34 instances where the indicator turned negative. In 25 of the 34 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 74%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CORT as a result. In 60 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
CORT moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CORT crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for CORT entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where CORT advanced for three days, in 277 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
CORT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. CORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.146) is normal, around the industry mean (3.498). CORT's P/E Ratio (137.302) is considerably higher than the industry average of (-1.193). Projected Growth (PEG Ratio) (2.660) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (15.898) is also within normal values, averaging (440.869).
AXON | CORT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 54 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 100 Overvalued | |
PROFIT vs RISK RATING 1..100 | 83 | 59 | |
SMR RATING 1..100 | 81 | 76 | |
PRICE GROWTH RATING 1..100 | 66 | 64 | |
P/E GROWTH RATING 1..100 | 80 | 9 | |
SEASONALITY SCORE 1..100 | 30 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AXON's Valuation (90) in the Biotechnology industry is in the same range as CORT (100) in the Pharmaceuticals Other industry. This means that AXON’s stock grew similarly to CORT’s over the last 12 months.
CORT's Profit vs Risk Rating (59) in the Pharmaceuticals Other industry is in the same range as AXON (83) in the Biotechnology industry. This means that CORT’s stock grew similarly to AXON’s over the last 12 months.
CORT's SMR Rating (76) in the Pharmaceuticals Other industry is in the same range as AXON (81) in the Biotechnology industry. This means that CORT’s stock grew similarly to AXON’s over the last 12 months.
CORT's Price Growth Rating (64) in the Pharmaceuticals Other industry is in the same range as AXON (66) in the Biotechnology industry. This means that CORT’s stock grew similarly to AXON’s over the last 12 months.
CORT's P/E Growth Rating (9) in the Pharmaceuticals Other industry is significantly better than the same rating for AXON (80) in the Biotechnology industry. This means that CORT’s stock grew significantly faster than AXON’s over the last 12 months.
| AXON | CORT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 76% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 70% |
| MACD ODDS (%) | 2 days ago 79% | 2 days ago 74% |
| TrendWeek ODDS (%) | 2 days ago 69% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 71% | 2 days ago 63% |
| Advances ODDS (%) | 16 days ago 74% | 3 days ago 83% |
| Declines ODDS (%) | 2 days ago 70% | 7 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 86% |
| Aroon ODDS (%) | 2 days ago 83% | 2 days ago 36% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXON’s FA Score shows that 0 FA rating(s) are green while CORT’s FA Score has 1 green FA rating(s).
- AXON’s FA Score: 0 green, 5 red.
- CORT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXON’s TA Score shows that 4 TA indicator(s) are bullish while CORT’s TA Score has 4 bullish TA indicator(s).
- AXON’s TA Score: 4 bullish, 5 bearish.
- CORT’s TA Score: 4 bullish, 6 bearish.
Price Growth
AXON (@Aerospace & Defense) experienced а -27.37% price change this week, while CORT (@Biotechnology) price change was -10.47% for the same time period.
The average weekly price growth across all stocks in the @Aerospace & Defense industry was +5.10%. For the same industry, the average monthly price growth was -0.96%, and the average quarterly price growth was -12.76%.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
AXON is expected to report earnings on Mar 02, 2027.
CORT is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Aerospace & Defense (+5.10% weekly)Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
CORT and
Correlation & Price change
A.I.dvisor indicates that over the last year, CORT has been loosely correlated with VTVT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then VTVT could also see price increases.
| Ticker / NAME | Correlation To CORT | 1D Price Change % | ||
|---|---|---|---|---|
| CORT | 100% | -2.23% | ||
| VTVT - CORT | 49% Loosely correlated | -0.85% | ||
| TENX - CORT | 41% Loosely correlated | -5.06% | ||
| AGIO - CORT | 41% Loosely correlated | +1.21% | ||
| ARCT - CORT | 37% Loosely correlated | -1.05% | ||
| AXON - CORT | 36% Loosely correlated | -0.21% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IFEB | 31.45 | -0.18 | -0.58% |
| Innovator International Developed Power Buffer ETF February (IFEB) | |||
| WDI | 11.69 | -0.16 | -1.35% |
| Western Asset Diversified Income Fund | |||
| DAPP | 13.88 | -0.27 | -1.91% |
| VanEck Digital Transformation ETF (DAPP) | |||
| PSLV | 16.64 | -0.66 | -3.82% |
| Sprott Physical Silver Trust | |||
| CEGX | 12.08 | -0.79 | -6.17% |
| Tradr 2X Long CEG Daily ETF (CEGX) | |||